O	O	0	10	Expression	Expression	B-NP	NN	O	10	SUB	O
O	O	11	13	of	of	B-PP	IN	O	1	NMOD	O
T1	B-Protein	14	19	PILOT	PILOT	B-NP	NN	B-protein	8	NMOD	B-protein
O	O	19	20	,	,	O	,	O	8	P	O
O	O	21	22	a	a	B-NP	DT	O	8	NMOD	O
O	O	23	31	putative	putative	I-NP	JJ	O	8	NMOD	O
O	O	32	45	transcription	transcription	I-NP	NN	B-protein	8	NMOD	B-protein
O	O	46	52	factor	factor	I-NP	NN	I-protein	2	PMOD	I-protein
O	O	52	53	,	,	O	,	O	8	P	O
O	O	54	62	requires	require	B-VP	VBZ	O	0	ROOT	O
O	O	63	66	two	two	B-NP	CD	O	12	NMOD	O
O	O	67	74	signals	signal	I-NP	NNS	O	10	OBJ	O
O	O	75	78	and	and	O	CC	O	10	VMOD	O
O	O	79	81	is	be	B-VP	VBZ	O	10	VMOD	O
O	O	82	93	cyclosporin	cyclosporin	B-NP	NN	O	16	NMOD	O
O	O	94	95	A	A	I-NP	NN	O	17	AMOD	O
O	O	96	105	sensitive	sensitive	B-ADJP	JJ	O	14	PRD	O
O	O	106	108	in	in	B-PP	IN	O	10	VMOD	O
O	O	109	110	T	T	B-NP	NN	B-cell_type	20	NMOD	B-cell_type
O	O	111	116	cells	cell	I-NP	NNS	I-cell_type	18	PMOD	I-cell_type
O	O	116	117	.	.	O	.	O	10	P	O

O	O	119	122	Few	Few	B-NP	JJ	O	3	NMOD	O
O	O	123	128	known	known	I-NP	JJ	O	3	NMOD	O
O	O	129	134	genes	gene	I-NP	NNS	O	9	NMOD	O
O	O	135	136	(	(	O	(	O	9	NMOD	O
T2	B-Protein	136	138	IL	IL	B-NP	NN	B-protein	6	NMOD	B-protein
T2	I-Protein	138	139	-	-	O	HYPH	I-protein	9	NMOD	I-protein
T2	I-Protein	139	140	2	2	B-NP	CD	I-protein	6	NMOD	I-protein
O	O	140	141	,	,	O	,	O	6	P	O
O	O	142	149	members	member	B-NP	NNS	O	19	NMOD	O
O	O	150	152	of	of	B-PP	IN	O	9	NMOD	O
O	O	153	156	the	the	B-NP	DT	O	15	NMOD	O
T11	B-Entity	157	159	IL	IL	I-NP	NN	B-protein	15	NMOD	B-protein
T11	I-Entity	159	160	-	-	I-NP	HYPH	I-protein	15	NMOD	I-protein
T11	I-Entity	160	161	8	8	I-NP	CD	I-protein	15	NMOD	I-protein
T11	I-Entity	162	168	family	family	I-NP	NN	I-protein	10	PMOD	I-protein
O	O	168	169	,	,	O	,	O	19	P	O
T3	B-Protein	170	180	interferon	interferon	B-NP	NN	B-protein	19	NMOD	B-protein
T3	I-Protein	180	181	-	-	B-NP	HYPH	I-protein	19	P	I-protein
T3	I-Protein	181	186	gamma	gamma	I-NP	NN	I-protein	21	SUB	I-protein
O	O	186	187	)	)	O	)	O	19	NMOD	O
O	O	188	191	are	be	B-VP	VBP	O	54	VMOD	O
O	O	192	199	induced	induce	I-VP	VBN	O	21	VC	O
O	O	200	202	in	in	B-PP	IN	O	22	VMOD	O
O	O	203	204	T	T	B-NP	NN	B-cell_type	25	NMOD	B-cell_type
O	O	205	210	cells	cell	I-NP	NNS	I-cell_type	23	PMOD	I-cell_type
O	O	211	215	only	only	B-ADVP	RB	O	27	PMOD	O
O	O	216	223	through	through	B-PP	IN	O	22	VMOD	O
O	O	224	227	the	the	B-NP	DT	O	30	NMOD	O
O	O	228	236	combined	combined	I-NP	JJ	O	30	NMOD	O
O	O	237	243	effect	effect	I-NP	NN	O	27	PMOD	O
O	O	244	246	of	of	B-PP	IN	O	30	NMOD	O
O	O	247	254	phorbol	phorbol	B-NP	NN	O	34	NMOD	O
O	O	255	263	myristic	myristic	I-NP	JJ	O	34	NMOD	O
O	O	264	271	acetate	acetate	I-NP	NN	O	40	NMOD	O
O	O	272	273	(	(	O	(	O	37	DEP	O
O	O	273	276	PMA	PMA	B-NP	NN	O	37	DEP	O
O	O	276	277	)	)	O	)	O	34	NMOD	O
O	O	278	281	and	and	O	CC	O	40	NMOD	O
O	O	282	283	a	a	B-NP	DT	O	40	NMOD	O
O	O	284	286	Ca	Ca	I-NP	NN	O	31	PMOD	O
O	O	286	287	(	(	O	(	O	44	DEP	O
O	O	287	288	2	2	B-NP	CD	O	43	NMOD	O
O	O	288	289	+	+	O	SYM	O	44	DEP	O
O	O	289	290	)	)	O	)	O	46	NMOD	O
O	O	290	291	-	-	B-NP	HYPH	O	46	NMOD	O
O	O	291	300	ionophore	ionophore	I-NP	NN	O	49	NMOD	O
O	O	300	301	,	,	O	,	O	49	P	O
O	O	302	305	and	and	O	CC	O	49	NMOD	O
O	O	306	316	expression	expression	B-NP	NN	O	54	SUB	O
O	O	317	319	of	of	B-PP	IN	O	49	NMOD	O
O	O	320	324	only	only	B-NP	RB	O	53	NMOD	O
O	O	325	330	these	these	I-NP	DT	O	53	NMOD	O
T12	B-Entity	331	336	genes	gene	I-NP	NNS	B-DNA	50	PMOD	B-DNA
O	O	337	340	can	can	B-VP	MD	O	0	ROOT	O
O	O	341	343	be	be	I-VP	VB	O	54	VC	O
O	O	344	349	fully	fully	I-VP	RB	O	55	VMOD	O
O	O	350	360	suppressed	suppress	I-VP	VBN	O	55	VC	O
O	O	361	363	by	by	B-PP	IN	O	57	VMOD	O
O	O	364	375	Cyclosporin	Cyclosporin	B-NP	NN	O	60	NMOD	O
O	O	376	377	A	A	I-NP	NN	O	58	PMOD	O
O	O	378	379	(	(	O	(	O	63	DEP	O
O	O	379	382	CyA	CyA	B-NP	NN	O	63	DEP	O
O	O	382	383	)	)	O	)	O	60	NMOD	O
O	O	383	384	.	.	O	.	O	54	P	O

O	O	385	387	We	We	B-NP	PRP	O	2	SUB	O
O	O	388	392	have	have	B-VP	VBP	O	0	ROOT	O
O	O	393	403	identified	identify	I-VP	VBN	O	2	VC	O
O	O	404	405	a	a	B-NP	DT	O	7	NMOD	O
O	O	406	414	putative	putative	I-NP	JJ	O	7	NMOD	O
O	O	415	428	transcription	transcription	I-NP	NN	B-protein	7	NMOD	B-protein
O	O	429	435	factor	factor	I-NP	NN	I-protein	3	OBJ	I-protein
O	O	435	436	,	,	O	,	O	7	P	O
O	O	437	447	designated	designate	B-VP	VBN	O	7	NMOD	O
T4	B-Protein	448	453	PILOT	PILOT	B-NP	NN	B-protein	9	VMOD	B-protein
O	O	453	454	,	,	O	,	O	7	P	O
O	O	455	459	with	with	B-PP	IN	O	7	NMOD	O
O	O	460	462	an	an	B-NP	DT	O	17	NMOD	O
O	O	463	472	identical	identical	I-NP	JJ	O	17	NMOD	O
O	O	473	477	dual	dual	I-NP	JJ	O	17	NMOD	O
O	O	478	484	signal	signal	I-NP	NN	O	17	NMOD	O
O	O	485	496	requirement	requirement	I-NP	NN	O	12	PMOD	O
O	O	497	500	for	for	B-PP	IN	O	17	NMOD	O
O	O	501	511	expression	expression	B-NP	NN	O	18	PMOD	O
O	O	511	512	.	.	O	.	O	2	P	O

O	O	513	522	Induction	Induction	B-NP	NN	O	6	SUB	O
O	O	523	525	of	of	B-PP	IN	O	1	NMOD	O
O	O	526	529	the	the	B-NP	DT	O	5	NMOD	O
T5	B-Protein	530	535	PILOT	PILOT	I-NP	NN	B-DNA	5	NMOD	B-DNA
O	O	536	540	gene	gene	I-NP	NN	I-DNA	2	PMOD	I-DNA
O	O	541	543	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	544	554	detectable	detectable	B-ADJP	JJ	O	6	PRD	O
O	O	555	557	in	in	B-PP	IN	O	7	AMOD	O
O	O	558	563	human	human	B-NP	JJ	B-cell_type	11	NMOD	B-cell_type
O	O	564	565	T	T	I-NP	NN	I-cell_type	11	NMOD	I-cell_type
O	O	566	571	cells	cell	I-NP	NNS	I-cell_type	8	PMOD	I-cell_type
O	O	572	574	20	20	B-NP	CD	O	13	NMOD	O
O	O	575	578	min	min	I-NP	NN	O	14	PMOD	O
O	O	579	588	following	follow	B-PP	VBG	O	6	VMOD	O
O	O	589	599	activation	activation	B-NP	NN	O	14	PMOD	O
O	O	600	602	in	in	B-PP	IN	O	6	VMOD	O
O	O	603	606	the	the	I-PP	DT	O	18	NMOD	O
O	O	607	615	presence	presence	I-PP	NN	O	16	PMOD	O
O	O	616	618	of	of	I-PP	IN	O	18	NMOD	O
O	O	619	632	cycloheximide	cycloheximide	B-NP	NN	O	19	PMOD	O
O	O	633	636	and	and	O	CC	O	6	VMOD	O
O	O	637	639	is	be	B-VP	VBZ	O	6	VMOD	O
O	O	640	645	fully	fully	I-VP	RB	O	24	VMOD	O
O	O	646	656	suppressed	suppress	I-VP	VBN	O	22	VC	O
O	O	657	659	by	by	B-PP	IN	O	24	VMOD	O
O	O	660	663	CyA	CyA	B-NP	NN	O	25	PMOD	O
O	O	663	664	.	.	O	.	O	6	P	O

O	O	665	668	The	The	B-NP	DT	O	3	NMOD	O
T6	B-Protein	669	674	PILOT	PILOT	I-NP	NN	B-protein	3	NMOD	B-protein
O	O	675	682	protein	protein	I-NP	NN	I-protein	4	SUB	I-protein
O	O	683	686	has	have	B-VP	VBZ	O	0	ROOT	O
O	O	687	688	a	a	B-NP	DT	O	7	NMOD	O
O	O	689	699	calculated	calculate	I-NP	VBN	O	7	NMOD	O
O	O	700	701	M	M	I-NP	NN	O	4	OBJ	O
O	O	701	702	(	(	O	(	O	10	DEP	O
O	O	702	703	r	r	B-NP	NN	O	10	DEP	O
O	O	703	704	)	)	O	)	O	7	NMOD	O
O	O	705	707	of	of	B-PP	IN	O	7	NMOD	O
O	O	708	710	42	42	B-NP	CD	B-protein	15	NMOD	B-protein
O	O	710	711	.	.	O	.	I-protein	15	NMOD	I-protein
O	O	711	712	6	6	B-NP	CD	I-protein	15	NMOD	I-protein
O	O	713	716	kDa	kDa	I-NP	NN	I-protein	11	PMOD	I-protein
O	O	717	720	and	and	O	CC	O	4	VMOD	O
O	O	721	729	contains	contain	B-VP	VBZ	O	4	VMOD	O
O	O	730	735	three	three	B-NP	CD	O	17	OBJ	O
T13	B-Entity	736	740	zinc	zinc	I-NP	NN	B-protein	20	NMOD	B-protein
T13	I-Entity	741	748	fingers	finger	I-NP	NNS	I-protein	18	NMOD	I-protein
O	O	749	751	of	of	B-PP	IN	O	18	NMOD	O
O	O	752	755	the	the	B-NP	DT	O	25	NMOD	O
T14	B-Entity	756	760	C2H2	C2H2	I-NP	NN	B-protein	25	NMOD	B-protein
T14	I-Entity	760	761	-	-	B-NP	HYPH	O	25	P	O
T14	I-Entity	761	765	type	type	I-NP	NN	O	21	PMOD	O
O	O	766	768	at	at	B-PP	IN	O	17	VMOD	O
O	O	769	772	the	the	B-NP	DT	O	30	NMOD	O
T15	B-Entity	773	781	carboxyl	carboxyl	I-NP	NN	B-protein	30	NMOD	B-protein
T15	I-Entity	781	782	-	-	B-NP	HYPH	I-protein	30	NMOD	I-protein
T15	I-Entity	782	790	terminus	terminus	I-NP	NN	I-protein	26	PMOD	I-protein
O	O	791	796	which	which	B-NP	WDT	O	30	NMOD	O
O	O	797	800	are	be	B-VP	VBP	O	31	SBAR	O
O	O	801	807	highly	highly	B-ADJP	RB	O	34	AMOD	O
O	O	808	818	homologous	homologous	I-ADJP	JJ	O	32	PRD	O
O	O	819	821	to	to	B-PP	TO	O	34	AMOD	O
O	O	822	825	the	the	B-NP	DT	O	39	NMOD	O
T16	B-Entity	826	830	zinc	zinc	I-NP	NN	B-protein	39	NMOD	B-protein
T16	I-Entity	831	837	finger	finger	I-NP	NN	I-protein	39	NMOD	I-protein
T16	I-Entity	838	845	regions	region	I-NP	NNS	I-protein	35	PMOD	I-protein
O	O	846	848	of	of	B-PP	IN	O	39	NMOD	O
O	O	849	852	the	the	B-NP	DT	O	43	NMOD	O
O	O	853	866	transcription	transcription	I-NP	NN	B-protein	43	NMOD	B-protein
O	O	867	874	factors	factor	I-NP	NNS	I-protein	40	PMOD	I-protein
T7	B-Protein	875	879	EGR1	EGR1	B-NP	NN	B-protein	49	NMOD	B-protein
O	O	879	880	,	,	O	,	O	49	P	O
T8	B-Protein	881	885	EGR2	EGR2	B-NP	NN	B-protein	49	NMOD	B-protein
O	O	885	886	,	,	O	,	O	49	P	O
O	O	887	890	and	and	O	CC	O	49	NMOD	O
T9	B-Protein	891	894	pAT	pAT	B-NP	NN	B-protein	43	NMOD	B-protein
T9	I-Protein	895	898	133	133	I-NP	CD	I-protein	49	NMOD	I-protein
O	O	898	899	.	.	O	.	O	4	P	O

O	O	900	902	In	In	B-PP	IN	O	12	VMOD	O
O	O	903	911	contrast	contrast	B-NP	NN	O	1	PMOD	O
O	O	912	914	to	to	B-PP	TO	O	2	NMOD	O
O	O	915	916	T	T	B-NP	NN	B-cell_type	5	NMOD	B-cell_type
O	O	917	922	cells	cell	I-NP	NNS	I-cell_type	3	PMOD	I-cell_type
O	O	922	923	,	,	O	,	O	12	P	O
O	O	924	926	in	in	B-PP	IN	O	12	VMOD	O
O	O	927	938	fibroblasts	fibroblast	B-NP	NNS	B-cell_type	7	PMOD	B-cell_type
T10	B-Protein	939	944	PILOT	PILOT	I-NP	NN	B-protein	11	NMOD	B-protein
O	O	945	949	gene	gene	I-NP	NN	O	11	NMOD	O
O	O	950	960	expression	expression	I-NP	NN	O	12	SUB	O
O	O	961	969	requires	require	B-VP	VBZ	O	0	ROOT	O
O	O	970	974	only	only	B-NP	RB	O	15	NMOD	O
O	O	975	978	one	one	I-NP	CD	O	13	AMOD	O
O	O	979	985	signal	signal	I-NP	NN	O	12	OBJ	O
O	O	986	987	(	(	O	(	O	18	DEP	O
O	O	987	990	PMA	PMA	B-NP	NN	O	18	DEP	O
O	O	990	991	)	)	O	)	O	15	NMOD	O
O	O	992	995	and	and	O	CC	O	12	VMOD	O
O	O	996	998	is	be	B-VP	VBZ	O	12	VMOD	O
O	O	999	1002	not	not	I-VP	RB	O	20	VMOD	O
O	O	1003	1011	affected	affect	I-VP	VBN	O	20	VC	O
O	O	1012	1014	by	by	B-PP	IN	O	22	VMOD	O
O	O	1015	1018	CyA	CyA	B-NP	NN	O	23	PMOD	O
O	O	1018	1019	.	.	O	.	O	12	P	O

O	O	1020	1024	This	This	B-NP	DT	O	2	NMOD	O
O	O	1025	1036	observation	observation	I-NP	NN	O	4	SUB	O
O	O	1037	1045	directly	directly	B-ADVP	RB	O	4	VMOD	O
O	O	1046	1058	demonstrates	demonstrate	B-VP	VBZ	O	0	ROOT	O
O	O	1059	1062	the	the	B-NP	DT	O	6	NMOD	O
O	O	1063	1072	existence	existence	I-NP	NN	O	4	OBJ	O
O	O	1073	1075	of	of	B-PP	IN	O	6	NMOD	O
O	O	1076	1077	a	a	B-NP	DT	O	11	NMOD	O
T17	B-Entity	1078	1081	Ca2	Ca2	I-NP	NN	B-protein	11	NMOD	B-protein
T17	I-Entity	1081	1082	+	+	B-NP	SYM	O	11	NMOD	O
T17	I-Entity	1083	1089	signal	signal	I-NP	NN	O	15	NMOD	O
T17	I-Entity	1089	1090	-	-	B-NP	HYPH	O	15	NMOD	O
T17	I-Entity	1090	1099	dependent	dependent	I-NP	JJ	O	15	NMOD	O
T17	I-Entity	1100	1110	regulatory	regulatory	I-NP	JJ	O	15	NMOD	O
T17	I-Entity	1111	1118	element	element	I-NP	NN	O	7	PMOD	O
O	O	1119	1129	obligatory	obligatory	B-ADJP	JJ	O	15	NMOD	O
O	O	1130	1133	for	for	B-PP	IN	O	16	AMOD	O
O	O	1134	1144	expression	expression	B-NP	NN	O	17	PMOD	O
O	O	1145	1147	of	of	B-PP	IN	O	18	NMOD	O
O	O	1148	1152	some	some	B-NP	DT	O	21	NMOD	O
T18	B-Entity	1153	1158	genes	gene	I-NP	NNS	O	19	PMOD	O
O	O	1159	1161	in	in	B-PP	IN	O	18	NMOD	O
O	O	1162	1163	T	T	B-NP	NN	B-cell_type	24	NMOD	B-cell_type
O	O	1164	1169	cells	cell	I-NP	NNS	I-cell_type	22	PMOD	I-cell_type
O	O	1170	1173	but	but	B-PP	CC	O	22	PMOD	O
O	O	1174	1177	not	not	B-PP	RB	O	27	PMOD	O
O	O	1178	1180	in	in	I-PP	IN	O	22	PMOD	O
O	O	1181	1192	fibroblasts	fibroblast	B-NP	NNS	B-cell_type	27	PMOD	B-cell_type
O	O	1192	1193	.	.	O	.	O	4	P	O

O	O	1194	1198	This	This	B-NP	DT	O	4	NMOD	O
O	O	1199	1211	differential	differential	I-NP	JJ	O	4	NMOD	O
O	O	1212	1222	expression	expression	I-NP	NN	O	4	NMOD	O
O	O	1223	1228	model	model	I-NP	NN	O	5	SUB	O
O	O	1229	1233	will	will	B-VP	MD	O	0	ROOT	O
O	O	1234	1236	be	be	I-VP	VB	O	5	VC	O
O	O	1237	1245	valuable	valuable	B-ADJP	JJ	O	6	PRD	O
O	O	1246	1248	in	in	B-PP	IN	O	6	VMOD	O
O	O	1249	1252	the	the	B-NP	DT	O	10	NMOD	O
O	O	1253	1263	dissection	dissection	I-NP	NN	O	21	NMOD	O
O	O	1264	1266	of	of	B-PP	IN	O	10	NMOD	O
O	O	1267	1270	the	the	B-NP	DT	O	15	NMOD	O
O	O	1271	1275	dual	dual	I-NP	JJ	O	15	NMOD	O
O	O	1276	1282	signal	signal	I-NP	NN	O	15	NMOD	O
O	O	1283	1290	pathway	pathway	I-NP	NN	O	11	PMOD	O
O	O	1291	1293	in	in	B-PP	IN	O	10	NMOD	O
O	O	1294	1295	T	T	B-NP	NN	B-cell_type	18	NMOD	B-cell_type
O	O	1296	1301	cells	cell	I-NP	NNS	I-cell_type	16	PMOD	I-cell_type
O	O	1302	1305	and	and	O	CC	O	21	NMOD	O
O	O	1306	1309	the	the	B-NP	DT	O	21	NMOD	O
O	O	1310	1317	effects	effect	I-NP	NNS	O	8	PMOD	O
O	O	1318	1320	of	of	B-PP	IN	O	21	NMOD	O
O	O	1321	1324	CyA	CyA	B-NP	NN	O	22	PMOD	O
O	O	1325	1329	upon	upon	B-PP	IN	O	21	NMOD	O
O	O	1330	1332	it	it	B-NP	PRP	O	24	PMOD	O
O	O	1332	1333	.	.	O	.	O	5	P	O
